1. Home
  2. DSGN vs OVLY Comparison

DSGN vs OVLY Comparison

Compare DSGN & OVLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSGN
  • OVLY
  • Stock Information
  • Founded
  • DSGN 2017
  • OVLY 1990
  • Country
  • DSGN United States
  • OVLY United States
  • Employees
  • DSGN N/A
  • OVLY N/A
  • Industry
  • DSGN Biotechnology: Pharmaceutical Preparations
  • OVLY Major Banks
  • Sector
  • DSGN Health Care
  • OVLY Finance
  • Exchange
  • DSGN Nasdaq
  • OVLY Nasdaq
  • Market Cap
  • DSGN 208.9M
  • OVLY 218.4M
  • IPO Year
  • DSGN 2021
  • OVLY N/A
  • Fundamental
  • Price
  • DSGN $3.77
  • OVLY $27.88
  • Analyst Decision
  • DSGN Hold
  • OVLY
  • Analyst Count
  • DSGN 1
  • OVLY 0
  • Target Price
  • DSGN $4.00
  • OVLY N/A
  • AVG Volume (30 Days)
  • DSGN 82.2K
  • OVLY 13.3K
  • Earning Date
  • DSGN 08-04-2025
  • OVLY 07-17-2025
  • Dividend Yield
  • DSGN N/A
  • OVLY 2.15%
  • EPS Growth
  • DSGN N/A
  • OVLY N/A
  • EPS
  • DSGN N/A
  • OVLY 2.97
  • Revenue
  • DSGN N/A
  • OVLY $78,869,000.00
  • Revenue This Year
  • DSGN N/A
  • OVLY N/A
  • Revenue Next Year
  • DSGN N/A
  • OVLY N/A
  • P/E Ratio
  • DSGN N/A
  • OVLY $9.39
  • Revenue Growth
  • DSGN N/A
  • OVLY 0.39
  • 52 Week Low
  • DSGN $2.60
  • OVLY $22.70
  • 52 Week High
  • DSGN $7.77
  • OVLY $32.24
  • Technical
  • Relative Strength Index (RSI)
  • DSGN 49.66
  • OVLY 65.56
  • Support Level
  • DSGN $3.33
  • OVLY $27.14
  • Resistance Level
  • DSGN $4.21
  • OVLY $27.78
  • Average True Range (ATR)
  • DSGN 0.24
  • OVLY 0.62
  • MACD
  • DSGN -0.02
  • OVLY 0.11
  • Stochastic Oscillator
  • DSGN 50.29
  • OVLY 100.00

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

About OVLY Oak Valley Bancorp (CA)

Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.

Share on Social Networks: